As health insurance companies and third-party benefit managers continue to use copay accumulators and maximizers to shift the cost of specialty drugs to patients, the ACR continues to advocate against programs that limit copay assistance.
Connect with Your Members of Congress in August
Legislators head home to their districts in August, providing a chance for you to engage them in personal conversations about healthcare policies and how their work affects rheumatology practices and patients.
Calling All Advocates: Advocates for Arthritis Applications Now Open
Applications are open for this year’s Advocates for Arthritis, which brings together patients and rheumatology professionals to advocate on Capitol Hill. It will be held Sept. 26–27 in Washington, D.C.
Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting
Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.
Tennessee Rheumatology Society: Keeping Pace with State Growth
The Tennessee Rheumatology Society is helping rheumatology professionals in the state keep pace with a rapidly growing population by supporting both current practitioners and fellows in the state’s two rheumatology fellowship programs.
After Pushback, Cigna Delays Modifier 25 Policy Changes
After significant pushback from the AMA, ACR and other medical societies, Cigna has delayed implementation of changes to its modifier 25 reimbursement policy, originally scheduled to take effect May 25.
ACR to Lead Resolutions at June AMA House of Delegates Meeting
The ACR will co-lead with the American Society of Clinical Oncology a resolution on in-office dispensing of specialty drugs and will lead 10 other specialty societies to advance a resolution on the proposed NIH Public Access Plan and equitable access to quality clinical research.
Slow but Steady: 2023 State Legislative Progress
This legislative season has seen key pharmacy benefit manager reforms but slow movement on other issues, such as copay accumulators and utilization management. The ACR is also monitoring emerging topics, such as biomarker testing and post-public health emergency telehealth reforms.
ACR Hill Day Participants Ask Congress to Address Medical Workforce Shortage
Nearly 70 rheumatologists and rheumatology professionals convened in Washington, D.C., to advocate on behalf of legislation that would preserve and help to grow America’s healthcare workforce.
ACR Expresses Concerns with MedPAC’s Drug Pricing Recommendations
In April, the Medicare Payment Advisory Committee voted to recommend a change in the add-on payment for Part B drugs, including reducing payment for more expensive drugs. The ACR sent a letter to MedPAC expressing concerns about the significant impacts such policies would have on rheumatologists.
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 96
- Next Page »